Full description
The SURFSUP 1 Trial is a multi-centre, unblinded, randomised controlled, non-inferiority trial. The trial is investigating whether supraglottic airway surfactant treatment is non-inferior to minimally invasive surfactant treatment (MIST) provided by laryngoscopy and thin catheter, in preventing mechanical ventilation (MV) or repeat surfactant within 72 hours of randomisation, in preterm infants with a diagnosis of respiratory distress syndrome. The trial aimed to enrol at least 1000 preterm infants in 57 neonatal units in seven countries. Enrolment commenced in February 2021 and was completed in August 2026. Full details of the trial design are available in the trial protocol.
Registration
WHO Universal Trial Number: U1111-1258-2109
ANZCTR Trial ID: ACTRN12620001184965
Issued: 2026-10-27
Created: 2026-10-27
User Contributed Tags
Login to tag this record with meaningful keywords to make it easier to discover
- DOI : 10.26180/34818255.V1
